LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

SRS Capital Advisors, Inc.'s Holding History (CIK: 0001586767)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 28 Value ($000) $0 Avg Close $1.73 Range $1.53 - $2.09
Q3 2025
Shares 118 Value ($000) $0 Avg Close $1.18 Range $0.85 - $1.80